Valuation (9%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -14.86 | 35.30 |
PEG Ratio (TTM) | -0.60 | 4.21 |
P/S Ratio (TTM) | 1.02 | 1.10 |
P/B Ratio (TTM) | 18.35 | 4.62 |
P/FCF Ratio (TTM) | -10.98 | 71.39 |
Price to 5YR AVG Earnings Ratio | N/A | 26.00 |
Price to 5YR AVG FCF Ratio | N/A | 19.05 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -21.33% | 4.21% |
ROE (TTM) | -101.84% | 13.60% |
Net Profit Margin (TTM) | -6.85% | 3.20% |
ROIC 5YR AVG | N/A | 18.34% |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -2.56% | -141.01% | N/A |
Revenue | 11.03% | 23.76% | N/A |
Net Income | -1.98% | -126.86% | N/A |
Cash Flow | -684.66% | -372.48% | N/A |
Health (46%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.61 | 1.10 |
Quick Ratio (TTM) | 3.02 | 1.26 |
D/E Ratio (TTM) | 1.71 | 0.80 |
Interest Coverage (TTM) | -5.94 | 1.22 |
Piotroski F-Score | 2 | 7 |
Altman Z-Score | 3.34 | 3.47 |
LTL to 5YR AVG FCF | N/A | 3.11 |
Shares Outstanding Growth 5YR AVG | N/A | 0.57% |